Over the past week, DeSci has suddenly become a major topic of discussion once again. Since Binance Labs announced an investment in BIO Protocol, DeSci tokens such as VITA, GROW, and RSC have all experienced significant price surges, and they have maintained strong performance even during the recent market pullback. The previously low-key BIO Genesis event was immediately filled to capacity, and even the pump mini-experiment platform introduced by the BIO team before was "resurrected." It seems that now all the crypto hot money is flowing into DeSci.

The "Resurrection" of the Official Mini-Experiment

The meme market remains hot, and from various narrative angles, DeSci meme coins RIF and URO saw a nearly 20x price increase in less than two days. These two tokens come from the Pump.science platform, representing Rifamycin (RIF) and Urocanic Acid (URO).

Pump.science is a meme coin issuance platform launched by the Desci project Molecule DAO to support medical experiments in a meme coin manner. The tokens RIF and URO did not make much of a splash upon their launch, with a market cap hovering around $150,000. However, in the past few days, RIF and URO have continuously hit new highs, with their market cap reaching nearly $3 million at its peak, representing a 20x increase.

Pump.Science is a meme coin issuance platform launched by Molecule DAO of the Desci platform at this year's Token 2049 Solana Breakpoint conference, where players can purchase meme tokens representing drugs to participate in predicting drug effects and trading experimental data. For related reading, see: "Desci Leader Also Gets in the Game, Can Pump.science Play Well with 'Biological Science Meme'?" Pump.science's ability to "come back to life" in these past few days can be said to be inseparable from Binance's frequent actions in the DeSci field.

On November 8, Binance Labs announced an investment in BIO Protocol, stating that this investment marked Binance Labs' first foray into the Decentralized Science (DeSci) field. Shortly after this announcement, CZ attended the DeSci Day event held by Binance in Bangkok, where he discussed DeSci insights with Vitalik.

Regarding the BIO Protocol, it can be understood that it focuses on the medical research field, using blockchain technology to transform the early-stage scientific research financing and commercialization model. BIO Protocol founder Paul Kohlhaas has stated that BIO Protocol is dedicated to breaking the traditional scientific research funding dilemma, promoting global patient-driven research, and bringing about revolutionary change.

During the Desci Day event in Bangkok, Vitalik Buterin also showcased VitaDAO's first longevity product to CZ — VD001, which is a naturally high-dose spermidine supplement approved by the Thai FDA. CZ openly expressed, "Hope to see 1000 Desci projects next year."

Just in these past few days, various Desci project tokens have seen a significant price increase. In addition to RIF and URO mentioned at the beginning of the article, standout price surges were observed in VitaDAO's VITA token and Desci project ResearchCoin's RSC token.

The Favorite Track of Crypto Industry Leaders?

In fact, Desci's "reputation" has always been high.

As early as last year, the Desci concept caused a stir in the Chinese community, attracting CZ's attention with Desci's innovative approach to longevity research. He mentioned: He has actually been paying attention to biotechnology and thinking about how to use encryption technology to accelerate the flow of research funding in this field, and this post also became a key point in relighting Desci's fire.

Not only CZ, but as early as the end of last year, several industry leaders came to participate in the Desci conference held in Berlin, such as Zee Prime Capital co-founder Matti and Molecule CEO Tyler Golato. They actively shared their research and insights on Desci and expressed highly optimistic expectations for the Desci field.

Over a month ago, a16z also ventured into the Desci field for the first time, leading the investment in AminoChain, a Desci project dedicated to reforming the patient-contributed biospecimen stage in the healthcare field. Binance has also repeatedly hinted on social media that it is ready to heavily support scientific projects using blockchain technology. CZ once stated, "Innovation often happens in small groups because many excellent researchers cannot get sufficient funding."

It can be foreseen that, driven by Binance, the Desci field will attract more and more attention.

Which Projects Can Be Followed?

The BIO Protocol, which received investment from Binance Labs this time, aims to build a global scientific research funding and collaboration platform on the blockchain and DAO, hoping to use blockchain technology to address issues such as rare diseases, longevity research, and emerging health that are currently difficult to overcome. The BIO Protocol's network currently has seven BIO DAOs covering various areas such as cryopreservation, women's health, and mental health. The protocol's token BIO and the tokens of its partner DAOs can be considered as targets for attention.

BIO (BIO Protocol)

On August 9, BIO Protocol launched the first round of the Bio Genesis token sale, with an average price of $0.025, and a trading volume of $11.51 million. The second round of token sales took place on September 30, with BIO's average price already up by 72% to $0.043, and trading volume rising to $19.49 million. By the time of the public auction of the 2.5th round on November 10, the price of BIO had risen to $0.066, representing a 264% increase from the first round. Currently, the auction rounds of BIO Protocol have concluded.

VITA (VitaDAO)

VitaDAO is a group focused on funding early-stage longevity research, raising over $5 million and receiving investment from Pfizer Ventures. Since Vitalik showcased the first product VD001 developed by VitaDAO to CZ in Bangkok, VITA has entered a frenzy mode, with an intraday peak increase of 82.4%, a recent price of $3.12, a market cap exceeding $80 million, and a nearly threefold increase in the past week.

RSC (ResearchHub)

RSC is the native token of the ResearchHub platform, a project founded by Coinbase's co-founder Brian Armstrong. It is mainly used to reward users who post high-quality content on the platform (such as new papers, comments, peer reviews, and paper highlights). Whenever a user posts this content or receives likes, they will receive a certain amount of RSC tokens. The quantity of RSC can represent a user's reputation on the ResearchHub platform, with higher reputation granting more power (the authority to tag, edit, or delete low-quality content to ensure the quality of the platform's content).

ResearchHub also has a partnership with BIO protocol, and in the past week, RSC has seen a price surge of nearly 200%, once again reaching a market capitalization of $60 million after six months.

Furthermore, the article mentions the recent developments of Pump.science platform's tokens RIF and URO, as well as its incubator Molecule DAO, which are also worth paying attention to.

However, a review of token history reveals that in November 2023, RSC saw a nearly 40x increase in a month, followed by a sharp decline; VITA also reached around a $100 million market cap in 2022 and 2023 before retracing. Whether the support from Binance Lab, CZ, and Vitalik's enthusiastic "shilling" can propel Desci to new heights remains to be seen and will be tested by time.

欢迎加入律动 BlockBeats 官方社群：

Telegram 订阅群：https://t.me/theblockbeats

Telegram 交流群：https://t.me/BlockBeats_App

Twitter 官方账号：https://twitter.com/BlockBeatsAsia